Servier

Racecar speeding down a track
Biotech

Servier supercharges neuro pipeline with $450M deal

Servier plans to launch a phase 2 clinical trial for Fragile X syndrome candidate KER-0193 in Europe and the U.S. next year.
Darren Incorvaia Sep 8, 2025 2:30am
Servier

Servier hands Ideaya $210M upfront for ex-US rights to PKC asset

Sep 2, 2025 3:02pm
X ray illustration of a running person with pain in knee joint with blue background

Novartis culls ph. 2 knee pain trial testing anti-ADAMTS-5 asset

Apr 16, 2025 2:55pm
A series of dice with a bag on them illustrating cost cuts

Servier severing forces OPM to make 'drastic choices' to adapt

Apr 4, 2025 9:05am
Glowing puzzle piece fitting into puzzle

Servier pays $70M for Black Diamond's deprioritized cancer drug

Mar 19, 2025 7:53am
Photo of white clouds in a blue sky

Servier extends AI drug development pact with Google Cloud

Jan 16, 2025 9:11am